Dyne Therapeutics Inc Update on DYNE-101 for Myotonic Dystrophy Type 1 Conference Call Transcript - Thomson StreetEvents

Dyne Therapeutics Inc Update on DYNE-101 for Myotonic Dystrophy Type 1 Conference Call Transcript

Dyne Therapeutics Inc Update on DYNE-101 for Myotonic Dystrophy Type 1 Conference Call Transcript - Thomson StreetEvents
Dyne Therapeutics Inc Update on DYNE-101 for Myotonic Dystrophy Type 1 Conference Call Transcript
Published Jun 17, 2025
15 pages (9918 words) — Published Jun 17, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of DYN.OQ conference call or presentation 17-Jun-25 12:00pm GMT

  
Brief Excerpt:

...Operator Good day, and thank you for standing by. Welcome to Dyne Therapeutics update on DYNE-101 for Myotonic Dystrophy Type 1 conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Mia Tobias, Investor Relations. Please go ahead. Mia Tobias ...

  
Report Type:

Transcript

Source:
Company:
Dyne Therapeutics Inc
Ticker
DYN.OQ
Time
12:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Dyne Therapeutics Inc Topline Clinical Results from the DELIVER Trial of Z-Rostudirsen DYNE-251 in Duchenne Muscular Dystrophy Transcript – 2025-12-08 – US$ 54.00 – Edited Transcript of DYN.OQ conference call or presentation 8-Dec-25 1:00pm GMT

Dyne Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript – 2025-09-08 – US$ 54.00 – Edited Transcript of DYN.OQ presentation 8-Sep-25 1:15pm GMT

Dyne Therapeutics Inc at JPMorgan Healthcare Conference Transcript – 2025-01-15 – US$ 54.00 – Edited Transcript of DYN.OQ presentation 15-Jan-25 6:30pm GMT

Dyne Therapeutics Inc ACHIEVE Clinical Update Transcript – 2025-01-10 – US$ 54.00 – Edited Transcript of DYN.OQ corporate analyst meeting</ 10-Jan-25 1:00pm GMT

Dyne Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript – 2024-09-05 – US$ 54.00 – Edited Transcript of DYN.OQ presentation 5-Sep-24 8:05pm GMT

Dyne Therapeutics Inc DELIVER Clinical Update Transcript – 2024-09-03 – US$ 54.00 – Edited Transcript of DYN.OQ corporate analyst meeting</ 3-Sep-24 12:00pm GMT

Dyne Therapeutics Inc at JPMorgan Healthcare Conference Transcript – 2024-01-09 – US$ 54.00 – Edited Transcript of DYN.OQ presentation 9-Jan-24 10:15pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Dyne Therapeutics Inc Update on DYNE-101 for Myotonic Dystrophy Type 1 Conference Call Transcript" Jun 17, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Dyne-Therapeutics-Inc-Update-on-DYNE-101-for-Myotonic-Dystrophy-Type-1-Conference-Call-T16412271>
  
APA:
Thomson StreetEvents. (2025). Dyne Therapeutics Inc Update on DYNE-101 for Myotonic Dystrophy Type 1 Conference Call Transcript Jun 17, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Dyne-Therapeutics-Inc-Update-on-DYNE-101-for-Myotonic-Dystrophy-Type-1-Conference-Call-T16412271>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.